Lumos Pharma, Inc. logo

Lumos Pharma, Inc.

Woo! Lumos Pharma is in the house. Everybody just have a good time. We gonna make you lose your mind. Lumos party pills. Shake that! In another world. Lumos Pharma is developing and commercializing therapeutics for rare diseases like CTD (Creatine Transporter Deficiency) by partnering with Key Opinion Leaders in the field and the National Institutes of Health.

Lumos Pharma has an exclusive licensee of technology and discoveries made in laboratories at the University of Cincinnati.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://lumos-pharma.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
Address
4200 Marathon Blvd., Suite 200, TX 78756
Austin
United States
Email
Contact Number
+1 512-422-01550

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/lumos-pharma” connections=”true” suffix=””]

Lumos Pharmas academic partners at the University of Cincinnati conducted a knockout mouse study to develop LUM-001 a repurposed small molecule for the Treatment of Creatine Transporter Deficiency.

In Apr 2016, Lumos Pharma Raises $34Mn in Series B round to fund the clinical development of LMoo1. The financing was led by Deerfield Management Company and is joined by Clarus Ventures and Roche Venture Fund, New Enterprise Associates, Sant_ Ventures, and UCB. Previously, Lumos raised $14 Mn in series A round.